United States· US:0169-5308_758d66fb-0447-4f26-905f-595b182aebdc
RIVFLOZA
A nedosiran product containing nedosiran sodium, registered in United States by Novo Nordisk.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEDOSIRAN SODIUM
- Manufacturer
- Novo Nordisk
- Country
- United States (US)
- ATC code
- A16AX25
- ATC class
- Nedosiran
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1101695308011 VIAL in 1 CARTON (0169-5308-01) / .5 mL in 1 VIAL
- ndc110169-5308-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A16AX25
Nedosiran, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dcc58800-8097-4cf6-8cd4-dd65f538b09b GET /v1/drugs/dcc58800-8097-4cf6-8cd4-dd65f538b09b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "80",
"substance": "NEDOSIRAN SODIUM",
"productndc": "0169-5308",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/.5mL",
"application_number": "NDA215842",
"marketing_category": "NDA"
}See everything about nedosiran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.